These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 16764833)

  • 21. Effects of sustained administration of the serotonin and norepinephrine reuptake inhibitor venlafaxine: I. in vivo electrophysiological studies in the rat.
    Béïque J; de Montigny C; Blier P; Debonnel G
    Neuropharmacology; 2000 Jul; 39(10):1800-12. PubMed ID: 10884561
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Brain monoamine output alterations after a single venlafaxine challenge in experimental hepatic encephalopathy.
    Wikell C; Bergqvist PB; Hjorth S; Apelqvist G; Björk H; Bengtsson F
    Clin Neuropharmacol; 1998; 21(5):296-306. PubMed ID: 9789710
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neurochemical and behavioural characterization of milnacipran, a serotonin and noradrenaline reuptake inhibitor in rats.
    Mochizuki D; Tsujita R; Yamada S; Kawasaki K; Otsuka Y; Hashimoto S; Hattori T; Kitamura Y; Miki N
    Psychopharmacology (Berl); 2002 Jul; 162(3):323-32. PubMed ID: 12122491
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of fluoxetine on the ability of bupropion to modulate extracellular dopamine and norepinephrine concentrations in three mesocorticolimbic areas of rats.
    Li SX; Perry KW; Wong DT
    Neuropharmacology; 2002 Feb; 42(2):181-90. PubMed ID: 11804614
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of uptake 2 (or extraneuronal monoamine transporter) by normetanephrine potentiates the neurochemical effects of venlafaxine.
    Rahman Z; Ring RH; Young K; Platt B; Lin Q; Schechter LE; Rosenzweig-Lipson S; Beyer CE
    Brain Res; 2008 Apr; 1203():68-78. PubMed ID: 18321472
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serotonin and Norepinephrine Reuptake Inhibitors.
    Shelton RC
    Handb Exp Pharmacol; 2019; 250():145-180. PubMed ID: 30838456
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanism-based pharmacokinetic/pharmacodynamic modeling of rat prefrontal cortical dopamine response to dual acting norepinephrine reuptake inhibitor and 5-HT1A partial agonist.
    Li CS; Zhang L; Haske T; Dounay A; Gray D; Barta N; Brodfuehrer J; Lepsy C; Campbell B
    AAPS J; 2012 Jun; 14(2):365-76. PubMed ID: 22454087
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of halving the dose of venlafaxine to adjust for putative pharmacokinetic and pharmacodynamic changes in an animal model of chronic hepatic encephalopathy.
    Wikell C; Kugelberg FC; Hjorth S; Apelqvist G; Bengtsson F
    Clin Neuropharmacol; 2001; 24(6):324-33. PubMed ID: 11801807
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of venlafaxine on extracellular 5-HT, dopamine and noradrenaline in the hippocampus and on peripheral hormone concentrations in the rat in vivo.
    Piacentini MF; Clinckers R; Meeusen R; Sarre S; Ebinger G; Michotte Y
    Life Sci; 2003 Sep; 73(19):2433-42. PubMed ID: 12954452
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Desvenlafaxine succinate identifies novel antagonist binding determinants in the human norepinephrine transporter.
    Mason JN; Deecher DC; Richmond RL; Stack G; Mahaney PE; Trybulski E; Winneker RC; Blakely RD
    J Pharmacol Exp Ther; 2007 Nov; 323(2):720-9. PubMed ID: 17673606
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Desvenlafaxine: a new antidepressant or just another one?
    Pae CU
    Expert Opin Pharmacother; 2009 Apr; 10(5):875-87. PubMed ID: 19351235
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacological and behavioral characterization of D-473, an orally active triple reuptake inhibitor targeting dopamine, serotonin and norepinephrine transporters.
    Dutta AK; Santra S; Sharma H; Voshavar C; Xu L; Mabrouk O; Antonio T; Reith ME
    PLoS One; 2014; 9(11):e113420. PubMed ID: 25427177
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acute effect of milnacipran on the relationship between the locus coeruleus noradrenergic and dorsal raphe serotonergic neuronal transmitters.
    Bandoh T; Hayashi M; Ino K; Takada S; Ushizawa D; Hoshi K
    Eur Neuropsychopharmacol; 2004 Dec; 14(6):471-8. PubMed ID: 15589386
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential modulation of efficiency in a food-rewarded "differential reinforcement of low-rate" 72-s schedule in rats by norepinephrine and serotonin reuptake inhibitors.
    Dekeyne A; Gobert A; Auclair A; Girardon S; Millan MJ
    Psychopharmacology (Berl); 2002 Jul; 162(2):156-67. PubMed ID: 12110993
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of the effects of serotonin selective, norepinephrine selective, and dual serotonin and norepinephrine reuptake inhibitors on lower urinary tract function in cats.
    Katofiasc MA; Nissen J; Audia JE; Thor KB
    Life Sci; 2002 Aug; 71(11):1227-36. PubMed ID: 12106588
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Triple reuptake inhibition of serotonin, norepinephrine, and dopamine increases the tonic activation of α
    Jiang JL; El Mansari M; Blier P
    Prog Neuropsychopharmacol Biol Psychiatry; 2020 Dec; 103():109987. PubMed ID: 32474007
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Blockade of 5-hydroxytryptamine and noradrenaline uptake by venlafaxine: a comparative study with paroxetine and desipramine.
    Béïque JC; de Montigny C; Blier P; Debonnel G
    Br J Pharmacol; 1998 Oct; 125(3):526-32. PubMed ID: 9806336
    [TBL] [Abstract][Full Text] [Related]  

  • 38. S33005, a novel ligand at both serotonin and norepinephrine transporters: I. Receptor binding, electrophysiological, and neurochemical profile in comparison with venlafaxine, reboxetine, citalopram, and clomipramine.
    Millan MJ; Gobert A; Lejeune F; Newman-Tancredi A; Rivet JM; Auclair A; Peglion JL
    J Pharmacol Exp Ther; 2001 Aug; 298(2):565-80. PubMed ID: 11454918
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Estradiol Valerate and Remifemin ameliorate ovariectomy-induced decrease in a serotonin dorsal raphe-preoptic hypothalamus pathway in rats.
    Wang W; Cui G; Jin B; Wang K; Chen X; Sun Y; Qin L; Bai W
    Ann Anat; 2016 Nov; 208():31-39. PubMed ID: 27562857
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of selective serotonin and serotonin/noradrenaline reuptake inhibitors on extracellular serotonin in rat diencephalon and frontal cortex.
    Felton TM; Kang TB; Hjorth S; Auerbach SB
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Mar; 367(3):297-305. PubMed ID: 12644903
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.